Mr Russell Levine > Kirkland & Ellis LLP > Chicago, United States > Lawyer Profile

Kirkland & Ellis LLP
United States


Trial and ADR: patent infringement and trade secret misappropriation matters, disputes involving patent license agreements, PTAB proceedings, ITC Section 337 proceedings. Appellate: includes Federal Circuit appeals. Licensing: structuring, negotiating licensing-in and -out transactions. ILO Client Choice 2012 Award – Litigation, USA. Included in Chambers USA each year since 2008 with comments describing him as having a “strategic and client-oriented mindset,” being “an awe-inspiringly good litigator,” “an excellent patent litigator,” and “very bright and effective;” and praising him “for delivering pragmatic and well-reasoned legal advice in an understandable, business-friendly way.” Member, WIPO Center’s List of approved Mediators and Arbitrators; USPTO registered; Certified Licensing Professional.


Co-editor (with A. Liberman and P. Chrocziel): “International Licensing and Technology Transfer: Practice and the Law,” Kluwer Law Publishing


Licensing Executives Society (USA & Canada), Past President

Society of Automotive Engineers

Museum of Science & Industry, Past Chair of the Presidents Council


University of Chicago Law School (J.D., 1986); University of Michigan (B.S., 1982, economics); (B.S., 1982, interdisciplinary engineering).

Lawyer Rankings

United States > Intellectual property > Patents: licensing

Kirkland & Ellis LLP‘s extensive track record acting for licensors and licensees alike nourishes the practice with strong capabilities to negotiate mandates with a deep understanding of both perspectives. In addition to negotiating license agreements, the group is well versed in other commercial arrangements that are often implemented alongside of patent licensing deals, including joint development agreements, supply agreements, and service and technical assistance agreements. The team offers additional expertise in the development and implementation of patent licensing programs, often by way of corporate transactions. Key practitioners include David MacDonald in New York, who has a focus on pharmaceutical and biotechnology companies; Chicago-based trio Russell Levine, Adam Petravicius, and Seth Traxler, who leads the technology & IP transactions practice; and Shellie Freedman in New York, whose background in molecular and cell biology provides her with additional insight into life sciences transactions.